EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 52023XC00901
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)
C/2023/7331
OJ C, C/2023/901, 22.11.2023, ELI: http://data.europa.eu/eli/C/2023/901/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
Official Journal |
EN Series C |
|
C/2023/901 |
22.11.2023 |
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1) )
(Text with EEA relevance)
(C/2023/901)
Decision granting an authorisation
|
Reference of the decision (2) |
Date of decision |
Substance name |
Holder of the authorisation |
Authorisation number |
Authorised use |
Date of expiry of review period |
Reasons for the decision |
|
C(2023) 7331 |
15 November 2023 |
4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO) EC No: -, CAS No:- |
RSI ChemRep Europe Ltd, only representative of OraSure Technologies Inc., 27-30 Merchants Quay, Merchants House, Dublin 8, Ireland |
REACH/23/29/0 |
As a surfactant in in-vitro diagnostic device developer solution for the diagnosis of Human Immunodeficiency Virus and Hepatitis C Virus |
4 January 2033 |
In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the use of the substance and there are no suitable alternative substances or technologies. |
(1) OJ L 396, 30.12.2006, p. 1.
(2) The decision is available on the European Commission website at: Authorisation (europa.eu).
ELI: http://data.europa.eu/eli/C/2023/901/oj
ISSN 1977-091X (electronic edition)